Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany The Netherlands Spain
  • Study of RVU120 for Patients with Advanced Solid Tumors After Standard Treatments Have Failed

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Poland Spain
  • Study on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Denmark France Germany Hungary Italy +3
  • Study on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Lithuania Spain
  • Study of ELVN-002 with Trastuzumab and Chemotherapy for Patients with Advanced HER2+ Solid Tumors, Colorectal Cancer, and Breast Cancer

    Not recruiting

    1 1 1 1
    Belgium France Italy The Netherlands Spain
  • Study on Atezolizumab and Resiquimod Sulfate with Radiotherapy for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study of RLY-4008 for Patients with Cholangiocarcinoma and Other Advanced Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands Spain Sweden
  • Study of OMX-0407 for Patients with Previously Treated Unresectable Solid Tumors

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain
  • Study of Vusolimogene Oderparepvec and Nivolumab for Patients with Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Spain
  • Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain